Evaluation of the micral-test ® S, a qualitative immunologic patient self-test for microalbuminuria: The PROSIT project

Diabetic Medicine

Volumn 15, Issue 10, 1998, Pages 883-885

  Piehlmeier, W ^a,f   Renner, R ^b   Kimmerling, T ^a   Schramm, W ^a   Garbe, S ^c   Proetzsch, R ^c   Fahn, J ^d   Piwernetz, K ^e   Landgraf, R ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b KLINIKUM BOGENHAUSEN   (Germany)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

^d Center for Shoulder and Elbow Surgery   (Germany)

^e DiabCare Office Munich   (Germany)

^f Natl Res Ctr Environ and Hlth   (Germany)

Author keywords

Diabetic nephropathy; Microalbuminuria; Screening; Self testing

Indexed keywords

ALBUMIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DISEASE DURATION; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; QUALITATIVE DIAGNOSIS; SCREENING TEST; SELF EVALUATION; TURBIDIMETRY; URINARY EXCRETION;

ADULT; ALBUMINS; ALBUMINURIA; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SELF-EXAMINATION;

EID: 0031661741     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199810)15:10<883::AID-DIA684>3.0.CO;2-N     Document Type: Article

References (14)

1. Teutsch S, Newman J, Eggers P. The problem of diabetic renal failure in the United States: an overview. Am J Kidney Dis 1989; 13: 11-13.
2. Parving HH, Oxenboll B, Svendsen PA, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion in type 1 diabetes without overt proteinuria. New Engl J Med 1989; 320: 966-970.
3. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med 1984; 310: 356-360.
4. Deckert T, Yokoyama H, Mathiesen E, Rønn B, Jensen T, Feldt-Rasmussen B, et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. Br Med J 1996; 312: 871-873.
5. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736-741.
6. Winocour PH, Harland JOE, Millar JP, Laker MF, George K, Alberti MM. Microalbuminuria and associated risk factors in the community. Atherosclerosis 1992; 93: 71-81.
7. Stephenson JM, Fuller JH. The EURODIAB IDDM Complications Study Group and the WHO Multinational Study of Vascular Disease in Diabetes Study Group. Microalbuminuria is not rare before 5 years of IDDM. J Diab Compl 1994; 8: 166-173.
8. Gall MA, Rossing P, Skøtt P, Damsbo P, Vaag A, Bech K, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-661.
9. 1c und Mikroproteinurie im Bereich der KV Westfalen-Lippe 1988 bis 1994. Diabetes und Stoffwechsel 1995; 4: 427-428.
10. WHO/JDF Europe: Diabetes care and research in Europe: the St. Vincent Declaration. Diabetic Med 1990; 7: 360-364.
11. Landgraf-Leurs MM, Modi E, Horn K, Landgraf R. Immunoturbidimetric assay for the determination of microalbuminuria using the Hitachi analyser. J Clin Chem Clin Biochem 1987; 25: 683-687.
12. European IDDM Policy Group 1993. Consensus guidelines for the management of insulin-dependent (type 1) diabetes. Diabetic Med 1993; 10: 990-1005.
13. The NIDDM Policy Group. A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. Diabetic Med 1995; 12: 724.
14. Cohen OL, Close CF, Viberti GC. The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabetic Med 1987; 4: 437-440.